Yan Ling

Statistics

Publications

Citations

520

H-Index

Active since

2011

Affiliations

Cornell University(Current)

Weill Cornell Medicine

University of North Carolina at Chapel Hill

Texas A&M University

GlaxoSmithKline (Spain)

Yan Ling is an author at Cornell University specializing in mycobacterium tuberculosis infection, drug discovery, and mycobacterium tuberculosis pathogenesis.

ORCID

Publications per year

2011–2023

Publications

Type I interferon signaling mediates Mycobacterium tuberculosis–induced macrophage death

Li Zhang, Xiuju Jiang, Daniel Pfau et al. · The Journal of Experimental Medicine · 2020 · 120 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

N -methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis

Thulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou et al. · Proceedings of the National Academy of Sciences · 2016 · 98 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis

Ben Gold, Robert L. Smith, Quyen Thi Nguyen et al. · Journal of Medicinal Chemistry · 2016 · 48 citations · Full text

Medicine, Microbiology, Pharmacology +16

Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis

Ben Gold, Julia Roberts, Yan Ling et al. · Antimicrobial Agents and Chemotherapy · 2015 · 46 citations · Full text

Veterinary Medicine, Pharmacology, Diagnostic Microbiology +12

Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis

Thulasi Warrier, María Martínez-Hoyos, Manuel Marin-Amieva et al. · ACS Infectious Diseases · 2015 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 13